Life Sciences Tools & Services Contracts & Agreements
5,207 Contracts from 64 Life Sciences Tools & Services Companies
- 10x Genomics, Inc. (57 contracts)
- AbCellera Biologics Inc. (23)
- AbSci Corp (41)
- Adaptive Biotechnologies Corp (37)
- Agilent Technologies Inc (187)
- Akoya Biosciences, Inc. (30)
- Alpha Teknova, Inc. (48)
- ArcherDX, Inc. (22)
- ARQULE INC (83)
- ARYA Sciences Acquisition Corp III (49)
- Avantor, Inc. (39)
- Basis Global Technologies, Inc. (11)
- Berkeley Lights, Inc. (51)
- Bio-Matrix Scientific Group, Inc. (146)
- Bio-Rad Laboratories (42)
- Bio-Techne (95)
- BIOANALYTICAL SYSTEMS INC (149)
- BioNano Genomics, Inc (152)
- BRUKER CORP (58)
- Cambrex Corporation (35)
- CHAMPIONS ONCOLOGY, INC. (45)
- Charles River Laboratories (95)
- ChromaDex Corp. (176)
- CM Life Sciences II Inc. (59)
- Codex DNA, Inc. (50)
- CODEXIS INC (185)
- Cytek BioSciences, Inc. (24)
- ECO SCIENCE SOLUTIONS, INC. (65)
- EMMAUS LIFE SCIENCES, INC. (272)
- EVIO, INC. (99)
- FLUIDIGM CORP (181)
- HARVARD BIOSCIENCE INC (111)
- HighCape Capital Acquisition Corp. (72)
- Illumina Inc (140)
- INTERNATIONAL ISOTOPES INC (3)
- InventaBioTech Inc. (6)
- IQVIA Holdings Inc. (118)
- IsoPlexis Corp (32)
- Lifesci Acquisition II Corp. (49)
- Luminex Corporation (108)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (70)
- Medpace Holdings, Inc. (38)
- Mettler Toledo (38)
- Miromatrix Medical Inc. (64)
- NanoString Technologies Inc (108)
- NEOGENOMICS INC (101)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (114)
- PerkinElmer (190)
- Personalis, Inc. (71)
- Pharma-Bio Serv, Inc. (44)
- PPD, Inc. (31)
- PRA Health Sciences (57)
- PRESSURE BIOSCIENCES INC (107)
- Quanterix Corp (78)
- RAPID MICRO BIOSYSTEMS, INC. (36)
- Repligen Corporation (76)
- Seer, Inc. (37)
- SeqLL, Inc. (93)
- Singular Genomics Systems, Inc. (38)
- Sotera Health Co (39)
- Syneos Health (132)
- Thermo Fisher Scientific (245)
- VG Acquisition Corp. (63)
- Waters Corporation (92)
- Business Finance (1,929 contracts from 64 companies)
- Business Formation (1 | 1)
- Business Operations (314 | 60)
- Human Resources (1,485 | 62)
- Intellectual Property (168 | 28)
- Mergers & Acquisitions (96 | 36)
- Real Estate (211 | 37)
- Uncategorized (1,003 | 63)
- Amended and Restated At-the-Market Sales Agreement, dated December 27, 2024, by and among Personalis, Inc., Piper Sandler & Co. and BTIG, LLC (Personalis, Inc., Filed With SEC on December 27, 2024)
- Limited Guarantee, dated as of December 22, 2024, by and between Deerfield Private Design Fund IV, L.P., and Singular Genomics Systems, Inc (Singular Genomics Systems, Inc., Filed With SEC on December 23, 2024)
- Form of Voting and Support Agreement (Singular Genomics Systems, Inc., Filed With SEC on December 23, 2024)
- Agreement and Plan of Merger, dated as of December 22, 2024, by and among Singular Genomics Systems, Inc., Singular Genomics Parent, LLC and Saturn Merger Sub, Inc (Singular Genomics Systems, Inc., Filed With SEC on December 23, 2024)
- Investment Agreement, dated December 19, 2024, by and between Personalis, Inc. and Merck Sharp & Dohme LLC (Personalis, Inc., Filed With SEC on December 19, 2024)
- Underwriting Agreement, dated as of December (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 18, 2024)
- Share Purchase Agreement, dated December 16, 2024, by and among Quanterix Corporation (Quanterix Corp, Filed With SEC on December 17, 2024)
- Form Indemnification Agreement (Akoya Biosciences, Inc., Filed With SEC on December 13, 2024)
- Separation Agreement and Release, dated December 6, 2024 and effective December 13, 2024 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on December 13, 2024)
- Sales Agreement, dated December 11, 2024, by and between Quantum-Si Incorporated and Canaccord Genuity LLC (HighCape Capital Acquisition Corp., Filed With SEC on December 11, 2024)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (2025 RSU Award) (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on December 5, 2024)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (2024 RSU Award) (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on December 5, 2024)
- Inotiv, Inc. Executive Change in Control Severance Plan (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Description of Capital Stock (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Amendment No. 3 to Stock Purchase Agreement, dated October 23, 2024, by and among Envigo Global Services, Inc., Inotiv, Inc. and Orient Bio, Inc (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Amendment No. 2 to Stock Purchase Agreement (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Offer Letter from the Company to Adrian Hardy, dated June 4, 2024 (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Letter Agreement, dated November 21, 2024, between the Company and SB Northstar LP (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on November 22, 2024)
- Amendment No. 4 to Credit and Security Agreement, dated July 31, 2024, by and between the Registrant and Midcap Financial Trust (Akoya Biosciences, Inc., Filed With SEC on November 14, 2024)
- Form of Restricted Stock Agreement under the 2023 Inducement Equity Incentive Plan (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- 2023 Inducement Equity Incentive Plan, as amended (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Offer Letter of Employment, dated as of August 22, 2024, by and between Quantum-Si Incorporated and Todd Bennett (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Letter of Employment, dated as of August 12, 2024, by and between Quantum-Si Incorporated and John Vieceli (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Separation and General Release Agreement (Codex DNA, Inc., Filed With SEC on November 7, 2024)
- Agreement and Plan of Merger among Staffing 360 Solutions, Inc, A36 Merger Sub Inc. and Atlantic International Corp, dated November 1, 2024 (SeqLL, Inc., Filed With SEC on November 7, 2024)
- Amended Offer Letter between the Registrant and Eric Esser dated April 17, 2024 (Codex DNA, Inc., Filed With SEC on November 7, 2024)
- Letter Agreement, dated November 7, 2024, between the Company and SB Northstar LP (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on November 7, 2024)
- Amendment No. 2 to the Commercialization and Reference Laboratory Agreement, dated September 20, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Personalis, Inc., Filed With SEC on November 6, 2024)
- Form of Securities Purchase Agreement dated October 30, 2024, between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series D Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series C Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Tenth Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2025, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on October 31, 2024)
- Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement (Non-Employee Director Form) under 2017 Incentive Award Plan (Bio-Rad Laboratories, Filed With SEC on October 31, 2024)
- Change in Control Severance Agreement by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Change in Control Severance Agreement by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Amendment to the Codexis, Inc. 2023 Employee Stock Purchase Plan (CODEXIS INC, Filed With SEC on October 31, 2024)
- Offer Letter by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Offer Letter by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Ken Suzuki dated September 16, 2024 (ARYA Sciences Acquisition Corp III, Filed With SEC on October 29, 2024)
- Employment Offer Letter by and between the Registrant and Adam Taich dated August 7, 2024 (10x Genomics, Inc., Filed With SEC on October 29, 2024)
